In the present study, HBP administration significantly reduced the elevated expressions of CD6, C1qb and C1qa, suggesting that HBP may alleviate symptoms of T2DM by enhancing immune responses, which aligns with the favorable results observed for inflammatory factors (Figure 1w–y). Here, C1QA is linked to type 2 diabetes mellitus.